As of Aug 28
| +0.36 / +1.29%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a -0.99% decrease from the last price of 28.28.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.